DNA methylation profiling in cancer: From single nucleotides towards the methylome

Molecular Biology

Volumn 41, Issue 5, 2007, Pages 723-736

  Moskalyov, E A ^a,b   Eprintsev, A T ^a   Hoheisel, J D ^b  

^a VORONEZH STATE UNIVERSITY   (Russian Federation)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carcinogenesis; CG dinucleotides; CpG islands; DNA methylation; DNA microarrays; High throughput analysis; Large scale analysis; Methods of DNA methylation profiling; Methylome; Oligonucleotide microarrays

Indexed keywords

EID: 35348953281     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893307050068     Document Type: Article

References (120)

1. Weinberg R.A. 2007. The Biology of Cancer. N.Y.: Garland Science.
2. Vanyushin B.F., Tkacheva S.G., Belozersky A.N. 1970. Rare bases in animal DNA. Nature. 225, 948-949.
3. Hotchkiss R.D. 1948. The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. J. Biol. Chem. 168, 315-332.
4. Vanyushin B.F., Mazin A.L., Vasiliev V.K., Belozersky A.N. 1973. The content of 5-methylcytosine in animal DNA: The species and tissue specificity. Biochim. Biophys. Acta. 299, 397-403.
5. Burthseva N.N., Azizov Yu.M., Itkin B.Z., Vanyushin B.F. 1977. Changes in cattle lymphocyte DNA methylation in chronic lympholeukosis. Biokhimiya. 42, 1690-1696.
6. Wigler M., Levy D., Perucho M. 1981. The somatic replication of DNA methylation. Cell. 24, 33-40.
7. Stein R., Gruenbaum Y., Pollack Y., Razin A., Cedar H. 1982. Clonal inheritance of the pattern of DNA methylation in mouse cells. Proc. Natl. Acad. Sci. USA. 79, 61-65.
8. Bestor T.H., Laudano A.P., Mattaliano R., Ingram V.M. 1988. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells: The carboxylterminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203, 971-983.
9. Baylin S.B., Hoppener J.W., de Bustros A., Steenbergh P.H., Lips C.J., Nelkin B.D. 1986. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res. 46, 2917-2922.
10. Greger V., Passarge E., Hopping W., Messmer E., Horsthemke B. 1989. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum. Genet. 83, 155-158.
11. Sakai T., Toguchida J., Ohtani N., Yandell D.W., Rapaport J.M., Dryja T.P. 1991. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet. 48, 880-888.
12. Russo V.E.A., Martienssen R.A., Riggs A.D. 1996. Epigenetic Mechanisms of Gene Regulation. N.Y.: Cold Spring Harbor Lab. Press.
13. Moskalyov E.A. 2004. Proc. Conf. "Philosophical Problems in Biology and Medicine," Voronezh, pp. 21-23.
14. Okano M., Bell D., Haber D., Li E. 1999. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 99, 247-257.
15. Baylin S.B., Ohm J.E. 2006. Epigenetic gene silencing in cancer: A mechanism for early oncogenic pathway addiction? Nature Rev. 6, 107-116.
16. Knudson A.G. 2001. Two genetic hits (more or less) to cancer. Nature Rev. Cancer. 1, 157-162.
17. Liu T., Raval A., Chen S.-S., Matkovic J.J., Byrd J.C., Plass C. 2006. CpG island methylation and expression of the secreted Frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res. 66, 653-658.
18. Calvisi D.F., Ladu S., Gorden A., Farina M., Corner E.A., Lee J.-S., Factor V.M., Thorgeirsson S.S. 2006. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 130, 1117-1128.
19. Aguilera O., Fraga M.F., Ballestar E., Paz M.F., Herranz M., Espada J., Garcia J.M., Munoz A., Esteller M., Gonzalez-Sancho J.M. 2006. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 25, 4116-4121.
20. Chim C., Fung T., Cheung W., Liang R., Kwong Y. 2004. SOCS1 and SHP1 hypermethylation in multiple myeloma: Implications for epigenetic activation of the Jak/STAT pathway. Blood. 103, 4630-4635.
21. He B., You L., Uematsu K., Zang K., Xu Z., Lee A.Y., Costello J.F., McCormick F., Jablons D.M. 2003. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc. Natl. Acad. Sci. USA. 100, 14,133-14,138.
22. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., Herman J.G. 2000. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60, 4366-4371.
23. Mertens D., Wolf S., Tschuch C., Mund C., Kienle D., Ohl S., Schroeter P., Lyko F., Dohner, Stilgenbauer S., Lichter P. 2006. Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism. Proc. Natl. Acad. Sci. USA. 103, 7741-7746.
24. Cui H., Horon I.L., Ohlsson R., Hamilton S.R., Feinberg A.P. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nature Med. 4, 1276-1280.
25. Feinberg A.P. 2004. The epigenetics of cancer etiology. Semin. Cancer Biol. 14, 427-432.
26. Holst C.R., Nuovo G.J., Esteller M., Chew K., Baylin S.B., Herman J.G, Tlsty T.D. 2003. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res. 63, 1596-1601.
27. Pepe M.S., Etzioni R., Feng Z., Potter J.D., Thompson M.L., Thornquist M., Winget M., Yasui Y. 2001. Phases of biomarker development for early detection of cancer. J. Natl. Cancer Inst. 93, 1054-1061.
28. Laird P.W. 2003. Early detection: The power and the promise of DNA methylation markers. Nature Rev. Cancer. 3, 253-266.
29. Crawford Y.G., Gauthier M.L., Joubel A., Mantei K., Kozakiewicz K., Afshari C.A., Tlsty T.D. 2004. Histologically normal human mammary epithelia with silenced p16 (INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell. 5, 263-273.
30. Yoo C., Jones P.A. 2006. Epigenetic therapy of cancer: Past, present, and future. Nat. Rev. Drug Discov. 5, 37-50.
31. Vanyushin B.F. 2005. Enzymatic DNA methylation: Epigenetic control over genetic functions of the cell. Biokhimiya. 70, 598-611.
32. International Human Genome Sequencing Consortium. 2001. Initial sequencing and analysis of the human genome. Nature. 409, 860-921.
33. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., Schubeler D. 2007. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nature Genet. 39, 457-466.
34. Feinberg A.P., Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 301, 89-92.
35. Babenko O.V., Zemlyakova V.V., Saakyan S.V., Brovkina A.F., Strelnikov V.V., Nemtsova M.V., Zaletaev B.V. 2002. RB1 and CDKN2A functional defects resulting in retinoblastoma. Mol. Biol. 36, 777-783.
36. Zemlyakova V.V., Zhevlova, A.I., Strelnikov, V.V., Lyubchenko L.N., Vishnevskaya Ya.B., Tretyakova V.A., Zaletaev D.V., Nemtsova M.V. 2003. Abnormal methylation of several tumor suppressor genes in sporadic breast cancer. Mol. Biol. 37, 696-703.
37. Ivanova T., Petrenko A., Gritsko T., Vinokourova S., Eshilev E., Kobzeva V., Kisseljov F., Kisseljova N. 2002. Methylation and silencing of the retinoic acid receptor-β 2 gene in cervical cancer. BMC Cancer. 2, 4.
38. Ivanova T., Vinokurova S., Petrenko A., Eshilev E., Solovyova N., Kisseljov F., Fisseljova N. 2004. Frequent hypermethylation of 5' flanking region of TIMP-2 gene in cervical cancer. Int. J. Cancer. 108, 882-886.
39. Loginov V.I., Malyukova A.V., Seryogin Yu.A., Hodyrev D.S, Kazubskaya T.P., Ermilova V.D., Garkavtseva R.F., Kisselev L.L, Zabarovsky E.R., Braga E.A. 2004. Methylation level of the RASSF1A gene in epithelial tumors of the kidney, mammary gland, and ovaries. Mol. Biol. 38, 654-667
40. Zemlyakova V.V., Strelnikov V.V., Zborovskaya I.B., Balukova O.V., Maiorova E.V., Vasil'ev E.V., Zaletaev D.V., Nemtsova M.V. 2004. Comparison of aberrant methylation of CpG islands in the p16/CDKN2A and p14/ARF promoters in non-small cell lung cancer and acute lymphoblastic leukemia, Mol. Biol. 38, 966-972.
41. Malyukova A.V., Loginov V.I., Hodyrev D.S., Kadyrova E.P., Pronina I.V., Ivanova T.A., Kisseljov, F.L., Zabarovsky E.R., Kisselyova N.P., Braga E.A. 2004. Methylation of the putative suppressor gene RASSF1 in primary cervical tumors. Mol. Biol. 38, 1005-1013.
42. Kekeeva T., Zhevlova A., Podistov Yu., Solov'eva Yu.V., Zaletaev D.V., Nemtsova M.V. 2006. Abnormal methylation of tumor suppressor genes and microsatellite instability in cervical precancer. Mol. Biol. 40, 224-230.
43. Plumb J.A., Steele N., Finn P.W., Brown R. 2004. Epigenetic approaches to cancer therapy. Biochem. Soc. Trans. 32, 1095-1097.
44. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., Welsh W., Yang C.S. 2003. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63, 7563-7570.
45. Issa J.-Pj., Gharibyan V., Cortes J., Jelinek J., Morris G., Verstovsek S., Talpaz M., Garcia-Manero G., Kantarjian H.M. 2005. Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate. J. Clin. Oncol. 23, 3948-3956.
46. Eden A., Gaudet F., Waghmare A., Jaenisch R. 2003. Chromosomal instability and tumors promoted by DNA hypomethylation. Science. 300, 455.
47. Suter C.M., Martin D.I., Ward R.L. 2004. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int. J. Colorect. Dis. 19, 95-101.
48. Kisseljova N.P., Kisseljov F.L. 2005. DNA demethylation and carcinogenesis. Biokhimiya. 70, 900-911.
49. Schumacher A., Kapranov P., Kaminsky Z. 2006. Microarray-based DNA methylation profiling: Technology and applications. Nucleic Acids Res. 34, 528-542.
50. Kawakami K., Brabender J., Lord R.V., Groshen S., Greenwald B.D., Krasna M.J., Yin J., Fleisher A.S., Abraham J.M., Beer D.G., Sidransky D., Huss H.T., Demeester T.R., Eads C., Laird P.W., Ilson D.H., Kelsen D.P., Harpole D., Moore M.B., Danenberg K.D., Danenberg P.V., Meltzer S.J. 2000. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst. 92, 1805-1811.
51. Zaletaev D., Nemtsova M., Strelnikov V., Babenko O.V., Vasil'ev E.V., Zemlyakova V.V., Zhevlova A.I., Drozd O.V. 2004. Diagnostics of epigenetic alterations in hereditary and oncological disorders. Mol. Biol. 38, 213-223.
52. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., Feinberg A.P. 2003. Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. Science. 299, 1753-1755.
53. Hoheisel J.D. 2006. Microarray technology: Beyond transcript profiling and genotype analysis. Nature Rev. Genet. 7, 200-210.
54. Bird A.P., Southern E.M. 1978. Use of restriction enzymes to study eukaryotic DNA methylation: 1. The methylation pattern in ribosomal DNA from Xenopus laevis. J. Mol. Biol. 118, 27-47.
55. Waalwijk C., Flavell R.A. 1978. DNA methylation at a CCGG sequence in the large intron of the rabbit β-globin gene: Tissue-specific variations. Nucleic Acids Res. 5, 4631-4634.
56. Frommer M., McDonald L., Millar D., Collis C., Watt F., Grigg G.M., Molloy P.L., Paul C.L. 1992. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA. 89, 1827-1831.
57. Gonzalgo M.L., Jones P.A. 2002. quantitative methylation analysis using methylation-sensitive single-nucleotide primer extension (Ms-SNuPE). Methods. 27, 128-133.
58. Singer-Sam J., LeBon J.M., Tanguay R.L., Riggs A.D. 1980. A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells. Nucleic Acids Res. 18, 687.
59. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA. 93, 9821-9826.
60. Xiong Zh., Laird P.W. 1997. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25, 2532-2534.
61. Dupont J.M., Tost J., Jammes H., Gut I.G. 2004. De novo quantitative bisulfite sequencing using the Pyrosequencing technology. Anal. Biochem. 333, 119-127.
62. Sanger F., Nicklein S., Coulson A.R. 1977. DNA sequencing with chain-terminator inhibitors. Proc. Natl. Acad. Sci. USA. 74, 5463-5467.
63. Warnecke P., Stirzaker C., Melki J., Millar D., Paul C., Clark S. 1997. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphitetreated DNA. Nucleic Acids Res. 25, 4422-4426.
64. Li L.C., Dahiya R. 2002. MethPrimer: Designing primers for methylation PCRs. Bioinformatics. 18, 1427-1431.
65. Warnecke P.M., Stirzaker C., Song J., Grunau C., Melki J.R., Clark S.J. 2002. Identification and resolution of artifacts in bisulfite sequencing. Methods. 27, 101-107.
66. Melki J.R., Vincent P.C., Brown R.D., Clark S.J. 2000. Hypermethylation of E-cadherin in leukemia. Blood. 95, 3208-3213.
67. Lewin J., Schmitt A.O., Adorjan P., Hildmann T., Piepenbrock C. 2004. Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates. Bioinformatics. 20, 3005-3012.
68. Callinan P.A., Feinberg A.P. 2006. The emerging science of epigenomics. Hum. Mol. Genet. 15, R95-R101.
69. Trinh B.N., Long T.I., Laird P.W. 2001. DNA methylation analysis by Methylight technology. Methods. 25, 456-462.
70. Ronaghi M., Uhlen M., Nyren P. 1998. A sequencing method based on real-time pyrophosphate. Science. 281, 363-365.
71. Tost J., Dunker J., Gut I.G. 2003. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. BioTechniques. 35, 152-156.
72. Tost J., Schatz P., Schuster M., Berlin K., Gut I.G. 2003. Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. Nucleic Acids Res. 31, e50.
73. Schatz P., Distler J., Berlin K., Schuster M. 2006. Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection. Nucleic Acids Res. 34, e59.
74. Corcoran M., Parker A., Orchard J., Davis Z., Wirtz M., Schmitz O.J., Oscier D. 2005. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica. 90, 1078-1088.
75. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., Marce S., Lopez-Guillermo A., Campo E., Montserrat E. 2003. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N. Engl. J. Med. 348, 1764-1775.
76. Adorján P., Distler J., Lipscher E., Model F., Müller J., Pelet C., Braun A., Florl A.R., Gutig D., Grabs G., Howe A., Kursar M., Lesche R., Leu E., Lewin A., Maier S., Müller V., Otto T., Scholz C., Schulz W.A., Seifert H.-H., Schwope I., Ziebarth H., Berlin K., Piepenbrock C., Olek A. 2002. Tumor class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res. 30, e21.
77. Guo J., Burger M., Nimmrich I., Maier S., Becker E., Genc B., Duff D., Rahmatpanah F., Chitma-Matsiga R., Shi H., Berlin K., Huang T.H.-M., Caldwell C.W. 2005. Differential DNA methylation of gene promoters in small B-cell lymphomas. Am. J. Clin. Pathol. 124, 430-439.
78. Zou H.Z., Yu B.M., Wang Z.W., Sun J.Y., Cang H., Gao F., Li D.H., Zhao R., Feng G.G., Yi J. 2002. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res. 8, 188-191.
79. Grady W.M., Rajput A., Lutterbaugh J.D., Markowitz S.D. 2001. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res. 61, 900-902.
80. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., Ehrlich M., Laird P.W. 2005. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res. 33, 6823-6836.
81. Yang A.S., Estecio M.R., Doshi K., Kondo Y., Tajara E.H., Issa J.-Pj. 2004. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 32, e38.
82. Kitahara O., Furukawa Y., Tanaka T., Kihara C., Ono K., Yanagawa R., Nita M.E., Takagi T., Nakamura Y., Tsunoda T. 2001. Alterations of gene expression during colorectal carcinogenesis revealead by c DNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Res. 61, 3544-3549.
83. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., Herman J.G. 2000. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60, 4366-4371.
84. Costello J.F., Fruhwald M.C., Smiraglia D.J., Rush L.J., Robertson G.P., Gao X., Wright F.A., Feramisco J.D., Peltomaki P., Lang J.C., Schuller D.E., Yu L., Bloomfield C.D., Caligiuri M.A., Yates A., Nishikawa R., Su Huang H., Petrelli N.J., Zhang X., O'Dorisio M.S., Held W.A., Cavenee W.K., Plass C. 2000. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns. Nature Genet. 24, 132-138.
85. Costello J.F., Smiraglia D.J., Plass C. 2002. Restriction landmark genome scanning. Methods. 27, 144-149.
86. Rush L., Raval A., Funchain P., Johnson A., Smith L. 2004. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res. 64, 2424-2433.
87. Raval A., Lucas D.M., Matkovic J.J., Bennett K.L., Liyanarachchi S., Young D.C., Rassenti L., Kipps T.J., Grever M.R., Byrd J.C., Plass C. 2005. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J. Clin. Oncol. 23, 3877-3885.
88. Azhikina T., Gainetdinov I., Skvortsova Y., Batrak A., Dmitrieva N., Sverdlov E. 2004. Non-methylated Genomic Sites Coincidence Cloning (NGSCC): An approach to large scale analysis of hypomethylated CpG patterns at predetermined genomic loci. Mol. Genet. Genomics. 271, 22-32.
89. Azhikina T.L., Sverdlov E.D. 2005. Study of tissue-specific CpG-methylation of DNA in extended genomic loci. Biokhimiya. 70, 722-730.
90. Barsky V., Kolchinsky A., Lysov Yu., Mirzabekov A. 2002. Biological microchips with hydrogel-immobilized nucleic acids, proteins, and other compounds: Properties and applications in genomics. Mol. Biol. 36, 563-584.
91. Syagailo Y.V., Kusnezow W., Hoheisel J.D. 2006. Microarray-based expression profiling: From technological basics to diagnostic perspectives. In: Apoptosis and Cancer Therapy. Eds. Debatin K.M., Fulda S. Weinheim: Wiley-VHC, pp. 60-85.
92. Matsuzaki H., Loi H., Dong S., Tsai Ya-Yu, Fang J., Law J., Di X., Liu W.-M., Yang G., Liu G., Huang J., Kennedy G.C., Ryder T.B., Marcus G.A., Walsh P.S., Shriver M.D., Puck J.M., Jones K.W., Mei R. 2004. Parallel genotyping of over 10,000 SNPs using a oneprimer assay on a high-density oligonucleotide array. Genome Res. 14, 414-425.
93. Shi H., Maier S., Nimmrich I., Yan P.S., Caldwell C.W., Olek A., Huang T.H.-M. 2003. Oligonucleotide-based microarray for DNA methylation analysis: Principles and applications. J. Cell. Biochem. 88, 138-143.
94. Gitan R.S., Shi H., Chen C.-M., Yan P.S., Huang T.H.-M. 2002. Methylation-specific oligonucleotide microarray: A new potential for high-throughput methylation analysis. Genome Res. 12, 158-164.
95. Hou P., Ji M., Li S., He N., Lu Zh. 2004. High-throughput method for detecting DNA methylation. J. Biochem. Biophys. Meth. 60, 139-150.
96. Mund C., Beier V., Bewerunge P., Dahms M., Lyko F., Hoheisel J.D. 2005. Array-based analysis of genomic DNA methylation patterns of the tumor suppressor gene p16INK4A promoter in colon carcinoma cell lines. Nucleic Acids Res. 33, e73.
97. Balog R.P., de Souza Y.P., Tang H.M., DeMasellis G.M., Gao B., Avila A., Gaban D.J., Mittelman D., Minna J.D., Luebke K.J., Garner H.R. 2002. Parallel assessment of CpG methylation by two-color hybridization with oligonucleotide arrays. Anal. Biochem. 309, 301-310.
98. Barker D.L., Theriault G., Che D., Dickinson T., Shen R., Kain R. 2003. Self-assembled random arrays: High-performance imaging and genomics applications on a high-density microarray platform. Soc. Photo-Optical Instrumentation Engineers. 4966, 1-11.
99. Bibikova M., Lin Zh., Zhou L., Chudin E., Garcia E.W., Wu B., Doucet D., Thomas N.J., Wang Y., Vollmer E., Goldmann T., Seifart C., Jiang W., Barker D.L., Chee M.S., Floros J., Fan J.-B. 2006. High-throughput DNA methylation profiling using universal bead arrays. Genome Res. 16, 383-393.
100. Baum M., Bielau S., Rittner N., Schmid K., Eggelbusch K., Dahms M., Schlauersbach A., Tahedl H., Beier M., Güimil R., Scheffler M., Hermann C., Fun J.-M., Wixmerten A., Rebscher H., Hönig M., Andreae C., Büchner D., Moschel E., Glathe A., Jäger E., Thom M., Greil A., Bestvater F., Obermeier F., Burgmaier J., Thome K., Weichert S., Hein S., Binnewies T., Foitzik V., Müller M., Stähler C.F., Stähler P.F. 2003. Validation of a novel, fully integrated and fexible microarray benchtop facility for gene expression profiling. Nucleic Acids Res. 31, e151.
101. Beier V., Hoheisel J. 2004. Charakterisierung von DNA- Methylierungsmustern mit Hilfe von Oligonukleotid-Microarrays. Bioforum. 5, 31-33.
102. Beier V., Mund C., Hoheisel J.D. 2007. Monitoring methylation changes in cancer. In: Advances in Biochemical Engineering/Biotechnology: Analytics of Protein-DNA Interactions. Ed. Seitz H. Heidelberg: Springer Verlag.
103. Moskalyov E.A., Beier V., Eprintsev A.T., Hoheisel J.D. 2006. Statusseminar Chiptechnologien: Entwicklung, Forschung und Routine. Abstract Book. Frankfurt am Main, p. 59.
104. Moskalyov A.A., Beier V., Hoheisel J.D., Eprintsev A.T. 2006. Biology: Science of the 21st century. Abstr. 10th Pushchino Young Scientists Conf. Pushchino, p. 32.
105. Kurg A., Tonisson N., Tolett J., Georgiou I., Shumaker L., Metspalu A. 2000. Arrayed primer extension: Solid phase four-color DNA resequencing and mutation detection technology. Genetic Testing. 4, 1-7.
106. Tonisson N., Zernant J., Kurg A., Pavel H., Slavin G., Roomere H., Meiel A., Hainaut P., Metspalu A. 2002. Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene. Proc. Natl. Acad. Sci. USA. 99, 5503-5508.
107. Beier M., Hoheisel J.D. 2002. Analysis of DNA-microarrays produced by inverse in situ oligonucleotide synthesis. J. Biotechnol. 94, 15-22.
108. Ching T.-T., Maunakea A.K., Jun P., Hong C., Zardo G., Pinkel D., Albertson D.G., Fridlyand J., Mao J.-H., Shchors K., Weiss W.A., Costello J.F. 2005. Epigenome analysis using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. Nature Genet. 37, 645-651.
109. Khulan B., Thompson R.F., Ye K., Fazzari M.J., Suzuki M., Stasiek E., Figueroa M.E., Glass J.L., Chen Q., Montagna C., Hatchwell E., Selzer R.R., Richmond T.A., Green R.D., Melnick A., Greallyl J.M. 2006. Comparative isoschizomer profiling of cytosine methylation: The HELP assay. Genome Res. 16, 1046-1055.
110. Hatada I., Fukasawa M., Kimura M., Morita S., Yamada K., Yoshikawa T., Yamanaka S., Endo C., Sakurada A., Sato M., Kondo T., Horri A., Ushijima T., Sasaki H. 2006. Genome-wide profiling of promoter methylation in human. Oncogene. 25, 3059-3064.
111. Wilson I.M., Davies J.J., Weber M., Brown C.J., Alvarez C.E., MacAulay C., Schubeler D., Lam W.L. 2006. Epigenomics: Mapping the methylome. Cell Cycle. 5, 155-158.
112. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. 1995. Serial analysis of gene expression. Science. 270, 484-487.
113. Hu M., Yao J., Cai L., Bachman K.E., van den Brule F., Velculescu V., Polyak K. 2005. Distinct epigenetic changes in the stromal cells of breast cancers. Nature Genet. 37, 899-905.
114. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., Berka J., Braverman M.S., Chen Y.-J., Chen Z., Dewell S.B., Du L., Fierro J.M., Gomes X.V., Godwin B.C., He W., Helgesen S., Ho C.H., Irzyk G.P., Jando S.C., Alenquer M.L.I., Jarvie T.P., Jirage K.B., Kim J.-B., Knight J.R., Lanza J.R., Leamon J.H., Lefkowitz S.M., Lei M., Li J., Lohman K.L., Lu H., Makhijani V.B., McDade K.E., McKenna M.P., Myers E.W., Nickerson E., Nobile J.R., Plant R., Puc B.P., Ronan M.T., Roth G.T., Sarkis G.J., Simons J.F., Simpson J.W., Srinivasan M., Tartaro K.R., Tomasz A., Vogt K.A., Volkmer G.A., Wang S.H., Wang Y., Weiner M.P., Yu P., Begley R.F., Rothberg J.M. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 437, 376-380.
115. Braslavsky I., Hebert B., Kartalov E., Quake S.R. 2003. Sequence information can be obtained from single DNA molecules. Proc. Natl. Acad. Sci. USA. 100, 3960.
116. Lagerqvist J., Zwolak M., Di Ventra M. 2006. Fast DNA sequencing via transverse electronic transport. Nano Lett. 6, 779-782.
117. Vire E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., van Eynde A., Bernard D., Vanderwinden J.M., Bollen M., Esteller M., Di Croce L., de Launoit Y., Fuks F. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 439, 871-874.
118. Schlesinger Y., Straussman R., Keshet I., Farkash S., Hecht M., Zimmerman J., Eden E., Yakhini Z., Ben-Shushan E., Reubinoff B.E., Bergman Y., Simon I., Cedar H. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nature Genet. 39, 232-236.
119. Ohm J.E., McGarvey K.M., Yu X., Cheng L., Schuebel K.E., Cope L., Mohammad H.P., Chen W., Daniel V.C., Yu W., Berman D.M., Jenuwein T., Pruitt K., Sharkis S.J., Watkins D.N., Herman J.G., Baylin S.B. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nature Genet. 39, 237-242.
120. Ohm J.E., Baylin S.B. 2007. Stem cell chromatin patterns: An instructive mechanism for DNA hypermethylation? Cell Cycle. 6, 1040-1043.